Agilent Technologies (A)
(Delayed Data from NYSE)
$137.32 USD
+2.34 (1.73%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $137.32 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$137.32 USD
+2.34 (1.73%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $137.32 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth F Momentum F VGM
Zacks News
Santa Clara, CA-based Agilent Technologies, Inc. was originally a spin-off from Hewlett-Packard. The company is an original equipment manufacturer (OEM) of a broad-based portfolio of test and measurement products serving multiple end markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG). The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers’ representatives, telesales and electronic commerce.
AMETEK (AME) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
AMETEK's (AME) first-quarter 2019 results benefit from solid organic growth and positive contributions from acquisitions.
Square (SQ) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Square's (SQ) expanding seller base is likely to benefit its gross payment volume, which is expected to drive the top-line growth in first-quarter 2019.
What's in Store for AMETEK (AME) This Earnings Season?
by Zacks Equity Research
AMETEK's (AME) first-quarter results are likely to benefit from positive contributions from acquisitions.
Amtek (AME) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Amtek (AME) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Why Is Agilent (A) Up 5.3% Since Last Earnings Report?
by Zacks Equity Research
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Tencent (TCEHY) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Tencent's (TCEHY) fourth-quarter results are likely to be hurt by the stalled video game approval process in China that was in place for the majority of 2018.
Booking Holdings (BKNG) Q4 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Booking Holdings' (BKNG) fourth-quarter results benefit from strong performance of its agency, merchant, advertising and other businesses.
Square (SQ) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Square's (SQ) fourth-quarter results gain from acquisition contributions, growing bitcoin revenues and robust product lines.
Top Ranked Momentum Stocks to Buy for February 28th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, February 28th:
Top Ranked Momentum Stocks to Buy for February 26th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, February 26th:
The Zacks Analyst Blog Highlights: McDonald's, CVS Health, Celgene, Coca-Cola and Agilent
by Zacks Equity Research
The Zacks Analyst Blog Highlights: McDonald's, CVS Health, Celgene, Coca-Cola and Agilent
Top Ranked Momentum Stocks to Buy for February 25th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, February 25th:
Are You Looking for a Top Momentum Pick? Why Agilent Technologies (A) is a Great Choice
by Zacks Equity Research
Does Agilent Technologies (A) have what it takes to be a top stock pick for momentum investors? Let's find out.
Agilent (A) Upgraded to Buy: Here's Why
by Zacks Equity Research
Agilent (A) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Top Research Reports for McDonald's, CVS Health & Celgene
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including McDonald's (MCD), CVS Health (CVS) and Celgene (CELG).
Agilent (A) Surpasses Earnings and Revenue Estimates in Q1
by Zacks Equity Research
Agilent (A) reports strong fiscal first-quarter results on broad-based growth in all its product lines.
Agilent Technologies (A) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Agilent (A) delivered earnings and revenue surprises of 4.11% and 1.02%, respectively, for the quarter ended January 2019. Do the numbers hold clues to what lies ahead for the stock?
Wal-Mart, CVS, Agilent, Hewlett-Packard and Kraft-Heinz are part of Zacks Earnings Preview
by Zacks Equity Research
Wal-Mart, CVS, Agilent, Hewlett-Packard and Kraft-Heinz are part of Zacks Earnings Preview
Will New Technologies Benefit Agilent (A) in Q1 Earnings?
by Zacks Equity Research
Agilent's (A) leadership position and strength in revenue segments are likely to aid fiscal first-quarter 2019 results.
3 Things to Know About Q4 Earnings Season
by Sheraz Mian
We continue to see the picture that emerged from the Q4 earnings season as not great, but it is not bad either.
Agilent Technologies (A) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Agilent (A) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Agilent (A) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
TE Connectivity (TEL) Q1 Earnings: What's in the Cards?
by Zacks Equity Research
TE Connectivity's (TEL) fiscal first-quarter 2019 results are expected to benefit from robust solutions portfolio and normalizing seasonal trend in the end-markets.
What's in the Offing for Waters Corp (WAT) in Q4 Earnings?
by Zacks Equity Research
Waters' (WAT) strong segmental and end-market performance is likely to drive fourth-quarter 2018 results.
Will Agilent (A) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Agilent (A) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.